Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Nicholas J Hawkins
Affiliation
School of Public Health, Imperial College London
ORCID
Career Start Year
1990
Papers
107
H Index
40
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36933623
Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer.
Gastroenterology
2023
36933623
Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer.
Gastroenterology
2023
33586625
Medical students as service learners: opportunities, risks and recommendations.
Educ Prim Care
2021
33586625
Medical students as service learners: opportunities, risks and recommendations.
Educ Prim Care
2021
33731104
Exploring why medical students still feel underprepared for clinical practice: a qualitative analysis of an authentic on-call simulation.
BMC Med Educ
2021
33731104
Exploring why medical students still feel underprepared for clinical practice: a qualitative analysis of an authentic on-call simulation.
BMC Med Educ
2021
32047231
Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Mod Pathol
2020
32047231
Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Mod Pathol
2020
29382774
Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Gut
2019
30620048
Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems.
Int J Cancer
2019
29382774
Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Gut
2019
31360895
Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing.
JNCI Cancer Spectr
2019
31360895
Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing.
JNCI Cancer Spectr
2019
30620048
Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems.
Int J Cancer
2019
29898989
Disruption of a -35 kb Enhancer Impairs CTCF Binding and <i>MLH1</i> Expression in Colorectal Cells.
Clin Cancer Res
2018
29880585
<i>MACROD2</i> Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors.
Cancer Discov
2018
30042065
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
Lancet Gastroenterol Hepatol
2018
29898989
Disruption of a -35 kb Enhancer Impairs CTCF Binding and <i>MLH1</i> Expression in Colorectal Cells.
Clin Cancer Res
2018
29880585
<i>MACROD2</i> Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors.
Cancer Discov
2018
30042065
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
Lancet Gastroenterol Hepatol
2018
27631337
Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.
Virchows Arch
2017
27631337
Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.
Virchows Arch
2017
27009937
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
Oncologist
2016
27440078
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
BMC Cancer
2016
27009937
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
Oncologist
2016
27332228
Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research.
Stud Health Technol Inform
2016
27267851
SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.
Clin Cancer Res
2016
27167335
Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.
Oncotarget
2016
27886675
Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients.
Cancer Genet
2016
27796585
Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.
Virchows Arch
2016
27671336
Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors.
Mol Cancer Res
2016
27796585
Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.
Virchows Arch
2016
27671336
Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors.
Mol Cancer Res
2016
27886675
Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients.
Cancer Genet
2016
27332228
Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research.
Stud Health Technol Inform
2016
27267851
SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.
Clin Cancer Res
2016
27167335
Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.
Oncotarget
2016
27440078
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
BMC Cancer
2016
25209439
Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
J Cancer Res Clin Oncol
2015
25726927
Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas.
Genes Chromosomes Cancer
2015
25474511
Institutional biobanking: an integral part of contemporary pathology practice.
Pathology
2015
26305864
Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
Br J Cancer
2015
26292916
Adaptive Tutorials Versus Web-Based Resources in Radiology: A Mixed Methods Comparison of Efficacy and Student Engagement.
Acad Radiol
2015
25209439
Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
J Cancer Res Clin Oncol
2015
26305864
Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
Br J Cancer
2015
26292916
Adaptive Tutorials Versus Web-Based Resources in Radiology: A Mixed Methods Comparison of Efficacy and Student Engagement.
Acad Radiol
2015
25726927
Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas.
Genes Chromosomes Cancer
2015
25474511
Institutional biobanking: an integral part of contemporary pathology practice.
Pathology
2015
24436049
Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.
Cancer Discov
2014
25464844
Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors.
Cell Rep
2014
1 - 50 of 214
Column Actions
Search
Recommended Authors
Daniela Hirsch
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Career Start Year
2012
Number of shared co-authors
2
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
1
Daniel L Worthley
South Australian Health and Medical Research Institute
Career Start Year
2001
Number of shared co-authors
6
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year
2000
Number of shared co-authors
2
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year
1999
Number of shared co-authors
1
Jonathan K Killian
From Foundation Medicine
Career Start Year
1999
Number of shared co-authors
3
Tobias Sj??blom
Uppsala University
Career Start Year
1999
Number of shared co-authors
1
William M Grady
. Fred Hutchinson Cancer Center
Career Start Year
1997
Number of shared co-authors
3
Robert Gryfe
University of Toronto
Career Start Year
1997
Number of shared co-authors
2
Manon van Engeland
Maastricht University Medical Center
Career Start Year
1996
Number of shared co-authors
0
David G Huntsman
University of British Columbia
Career Start Year
1994
Number of shared co-authors
11
Remond J A Fijneman
The Netherlands Cancer Institute
Career Start Year
1993
Number of shared co-authors
0
Otavia L Caballero
Ludwig Institute for Cancer Research Ltd.
Career Start Year
1993
Number of shared co-authors
5
Bhaskar Kallakury
Georgetown University
Career Start Year
1993
Number of shared co-authors
0
Gerrit A Meijer
The Netherlands Cancer Institute
Career Start Year
1992
Number of shared co-authors
0
Weei-Yuarn Huang
Nova Scotia Health Authority
Career Start Year
1992
Number of shared co-authors
0
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
3
Aaron Pollett
Mount Sinai Hospital
Career Start Year
1990
Number of shared co-authors
1
Bharati Bapat
Mt Sinai Hospital
Career Start Year
1988
Number of shared co-authors
5
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year
1988
Number of shared co-authors
8
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year
1986
Number of shared co-authors
0
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year
1986
Number of shared co-authors
5
Christopher L Corless
Oregon Health & Science University
Career Start Year
1985
Number of shared co-authors
1
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Career Start Year
1983
Number of shared co-authors
2
David D L Bowtell
Peter MacCallum Cancer Centre
Career Start Year
1983
Number of shared co-authors
7
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year
1982
Number of shared co-authors
0
David M Berman
Queen's University
Career Start Year
1982
Number of shared co-authors
0
Stephen N Thibodeau
Mayo Clinic
Career Start Year
1978
Number of shared co-authors
5
William E Grizzle
University of Alabama at Birmingham
Career Start Year
1974
Number of shared co-authors
0
Jeffrey S Ross
Foundation Medicine
Career Start Year
1974
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Robyn L Ward
University of Sydney
Co-authored papers
102
Dana Busam
J. Craig Venter Institute
Co-authored papers
4
Qi Zhao
University of Science and Technology Liaoning
Co-authored papers
4
Robert L Strausberg
Ludwig Institute for Cancer Research
Co-authored papers
4
Rodney J Scott
Co-authored papers
3
Adrienne Morey
The Canberra Hospital
Co-authored papers
3
Christine L Clarke
Westmead Institute for Medical Research, University of Sydney
Co-authored papers
2
Graeme Suthers
University of Adelaide
Co-authored papers
2
Lucy R Webster
Sydney West Area Health Service
Co-authored papers
2
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Co-authored papers
2
Karen Byth
Westmead Hospital
Co-authored papers
2
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Co-authored papers
2
Elizabeth L Salisbury
Prince of Wales Hospital
Co-authored papers
2
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Co-authored papers
2
Stephanie Bell
Co-authored papers
1
John M Mariadason
Olivia Newton-John Cancer Research Institute
Co-authored papers
1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
1
Kenneth W Kinzler
Co-authored papers
1
Fahd Al-Mulla
Dasman Diabetes Institute
Co-authored papers
1
Jack Goldblatt
King Edward Memorial Hospital for Women
Co-authored papers
1
Jitendra Jonnagaddala
NMC Royal Hospital
Co-authored papers
1
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham
Co-authored papers
1
Carme Camps
National Institute for Health Research Biomedical Research Centre
Co-authored papers
1
David I Quinn
USC Norris Comprehensive Cancer Center
Co-authored papers
1
Tom Walsh
University of Washington
Co-authored papers
1
David J Burn
Population Health Sciences Institute, Newcastle University
Co-authored papers
1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers
1
Susan R Davis
Co-authored papers
1
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers
1
Andrew J G Simpson
University of Hull
Co-authored papers
1
1 - 30